Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Epidemiology of colorectal cancer and surgical treatment

ECCO 15 - ESMO 34

20 - 24 Sep 2009

Published: 4 Nov 2009

Views: 13793

Rating:

Save

Dr Gabriela Moeslein - St Josef's Hospital, Bochum-Linden, Germany

Dr Gabriela Moeslein of St Josef's Hospital, Bochum-Linden, Germany, speaking at ECCO 15 - ESMO 34 in Berlin, 2009. Familial risk of colorectal cancer, CAP study on aspirin for colorectal cancer prevention, colorectal surgery, epidemiology in Germany and links to lynch syndrome.

Related Videos

ctDNA predicts early treatment response in HPV-associated anal cancer

Dr Phebe Mawuena Afi Havor - Moffitt Cancer Center, Tampa, USA

ctDNA predicts early treatment response in HPV-associated anal cancer ( Dr Phebe Mawuena Afi Havor - Moffitt Cancer Center, Tampa, USA )

Social determinants and survival outcomes in early-onset colorectal cancer in the US

Dr Jessica Paulus - Ontada, Boston, USA

Social determinants and survival outcomes in early-onset colorectal cancer in the US ( Dr Jessica Paulus - Ontada, Boston, USA )

Low frequency of dihydropyrimidine dehydrogenase variants in Mexican GI cancers should induce testing guideline reform

Dr Enrique Soto Pérez de Celis - University of Colorado Cancer Center, Aurora, USA

Low frequency of dihydropyrimidine dehydrogenase variants in Mexican GI cancers should induce testing guideline reform ( Dr Enrique Soto Pérez de Celis - University of Colorado Cancer Center, Aurora, USA )

ctDNA evaluation may play a prognostic role in stage III colon cancer treated with celecoxib

Dr Jonathan Andrew Nowak - Dana-Farber Cancer Institute, Boston, USA

ctDNA evaluation may play a prognostic role in stage III colon cancer treated with celecoxib ( Dr Jonathan Andrew Nowak - Dana-Farber Cancer Institute, Boston, USA )

Blood-based test may provide a convenient and effective option for CRC screening in the average-risk U.S. population

Dr Aasma Shaukat - NYU Grossman School of Medicine, New York, USA

Blood-based test may provide a convenient and effective option for CRC screening in the average-risk U.S. population ( Dr Aasma Shaukat - NYU Grossman School of Medicine, New York, USA )

New classification for identifying HR myeloma based on cytogenetic abnormalities

Dr Jill Corre - IUCT Oncopole, Toulouse, France

New classification for identifying HR myeloma based on cytogenetic abnormalities ( Dr Jill Corre - IUCT Oncopole, Toulouse, France )

Revolutionising myeloma treatment through immune profiling

Dr Romanos Sklavenitis-Pistofidis - Dana-Farber Cancer Institute, Boston, USA

Revolutionising myeloma treatment through immune profiling ( Dr Romanos Sklavenitis-Pistofidis - Dana-Farber Cancer Institute, Boston, USA )

Predicting tumour mutations from pathology images may help increase personalised medicine utilisation

Dr Rom Leidner - Providence Cancer Institute, Portland, USA

Predicting tumour mutations from pathology images may help increase personalised medicine utilisation ( Dr Rom Leidner - Providence Cancer Institute, Portland, USA )

ESMO 2024: Optimising the personalisation of prostate cancer treatment

Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg

ESMO 2024: Optimising the personalisation of prostate cancer treatment ( Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg )

More from ecancer